The multifaceted aspects of interstitial lung disease in rheumatoid arthritis

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Cavagna, Lorenzo ^a   Monti, Sara ^a   Grosso, Vittorio ^a   Boffini, Nicola ^a   Scorletti, Eva ^a   Crepaldi, Gloria ^a   Caporali, Roberto ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CORTICOSTEROID; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GOLIMUMAB; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RHEUMATOID FACTOR; RITUXIMAB; TOCILIZUMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ANKYLOSING SPONDYLITIS; BRONCHIOLITIS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG DOSE INCREASE; DRUG EFFICACY; ENTERITIS; FIBROSING ALVEOLITIS; HUMAN; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; ORGANIZING PNEUMONIA; OUTCOME ASSESSMENT; PATHOGENESIS; PNEUMOCONIOSIS; PSORIASIS; PSORIATIC ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SMOKING HABIT; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; METABOLISM; PATHOPHYSIOLOGY; SMOKING;

ARTHRITIS, RHEUMATOID; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; RISK FACTORS; SMOKING;

EID: 84885599387     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/759760     Document Type: Review

References (160)

1. Montecucco C., Cavagna L., Caporali R., Pain and rheumatology: an overview of the problem. European Journal of Pain Supplements 2009 3 2 105 109 2-s2.0-70350786391 10.1016/j.eujps.2009.07.006
2. Caporali R., Cavagna L., Montecucco C., Pain in arthritis. European Journal of Pain Supplements 2009 3 2 123 127 2-s2.0-70350782326 10.1016/j.eujps.2009.07.009
3. Govoni M., Caporali R., Predicting and managing the progression of structural damage in rheumatoid arthritis: where do we stand? Clinical and Experimental Rheumatology 2012 30 4 459 463
4. Krishnan E., Lingala B., Bruce B., Fries J. F., Disability in rheumatoid arthritis in the era of biological treatments. Annals of the Rheumatic Diseases 2012 71 2 213 218 2-s2.0-84855349340 10.1136/annrheumdis-2011-200354
5. Gabriel S. E., Crowson C. S., Kremers H. M., Doran M. F., Turesson C., O'Fallon W. M., Matteson E. L., Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis and Rheumatism 2003 48 1 54 58 2-s2.0-0037235944 10.1002/art.10705 (Pubitemid 36091647)
6. Cimmino M. A., Salvarani C., Macchioni P., Montecucco C., Fossaluzza V., Mascia M. T., Punzi L., Davoli C., Filippini D., Numo R., Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis. Rheumatology International 2000 19 6 213 217 2-s2.0-0033779761
7. Cavagna L., Boffini N., Cagnotto G., Inverardi F., Grosso V., Caporali R., Atherosclerosis and rheumatoid arthritis: more than a simple association. Mediators of Inflammation 2012 2012 8 147354 10.1155/2012/147354
8. Turesson C., Extra-articular rheumatoid arthritis. Current Opinion in Rheumatology 2013 25 3 360 366 10.1097/BOR.0b013e32835f693f
9. Gauhar U. A., Gaffo A. L., Alarcón G. S., Pulmonary manifestations of rheumatoid arthritis. Seminars in Respiratory and Critical Care Medicine 2007 28 4 430 440 2-s2.0-35848931682 10.1055/s-2007-985664 (Pubitemid 350194725)
10. de Lauretis A., Veeraraghavan S., Renzoni E., Connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ? Chronic Respiratory Disease 2011 8 1 53 82 2-s2.0-79952090277 10.1177/1479972310393758
11. Ellman P., Ball R. E., Rheumatoid arthritis with joint and pulmonary manifestations. The British Journal of Medicine 1948 2 4583 816 820 10.1136/bmj.2.4583.816
12. Rubin E. H., Pulmonary lesions in "rheumatoid disease" with remarks on diffuse interstitial pulmonary fibrosis. The American Journal of Medicine 1955 19 4 569 582 2-s2.0-28844493924
13. Kim E. J., Elicker B. M., Maldonado F., Webb W. R., Ryu J. H., Van Uden J. H., Lee J. S., King T. E. Jr., Collard H. R., Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. European Respiratory Journal 2010 35 6 1322 1328 2-s2.0-77953200219 10.1183/09031936.00092309
14. Ascherman D. P., Interstitial lung disease in rheumatoid arthritis. Current Rheumatology Reports 2010 12 5 363 369 2-s2.0-78149464737 10.1007/s11926-010-0116-z
15. Hunninghake G. W., Fauci A. S., Pulmonary involvement in the collagen vascular diseases. The American Review of Respiratory Disease 1979 119 3 471 503 2-s2.0-0018768627 (Pubitemid 9131394)
16. Cervantes-Perez P., Toro-Perez A. H., Rodriguez-Jurado P., Pulmonary involvement in rheumatoid arthritis. The Journal of the American Medical Association 1980 243 17 1715 1719 2-s2.0-0018843442 10.1001/jama.243.17.1715 (Pubitemid 10148804)
17. Koduri G., Norton S., Young A., Cox N., Davies P., Devlin J., Dixey J., Gough A., Prouse P., Winfield J., Williams P., Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology 2010 49 8 1483 1489 2-s2.0-77954717660 10.1093/rheumatology/keq035 keq035
18. Young A., Koduri G., Extra-articular manifestations and complications of rheumatoid arthritis. Best Practice and Research: Clinical Rheumatology 2007 21 5 907 927 2-s2.0-34548509677 10.1016/j.berh.2007.05.007 (Pubitemid 47377809)
19. Bongartz T., Nannini C., Medina-Velasquez Y. F., Achenbach S. J., Crowson C. S., Ryu J. H., Vassallo R., Gabriel S. E., Matteson E. L., Incidence and mortality of interstitial lung disease in rheumatoid arthritis-a population-based study. Arthritis and Rheumatism 2010 62 6 1583 1591 2-s2.0-77952933999 10.1002/art.27405
20. Cavagna L., Caporali R., Abdì-Alì L., Dore R., Meloni F., Montecucco C., Cyclosporine in anti-Jo1-positive patients with corticosteroid-refractory interstitial lung disease. Journal of Rheumatology 2013 40 4 484 492 10.3899/jrheum.121026
21. Nogee L. M., Dunbar A. E., Wert S. E., Askin F., Hamvas A., Whitsett J. A., A mutation in the surfactant protein C gene associated with familial interstitial lung disease. The New England Journal of Medicine 2001 344 8 573 579 2-s2.0-0035931973 10.1056/NEJM200102223440805 (Pubitemid 32167871)
22. Grutters J. C., du Bois R. M., Genetics of fibrosing lung diseases. European Respiratory Journal 2005 25 5 915 927 2-s2.0-18744374226 10.1183/09031936.05.00133404 (Pubitemid 40667693)
23. Mori S., Koga Y., Sugimoto M., Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis. Respiratory Medicine 2012 106 11 1591 1599 10.1016/j.rmed.2012.07.006
24. Saag K.G., Kolluri S., Koehnke R. K., Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. Arthritis and Rheumatism 1996 39 10 1711 1719 (Pubitemid 26331025)
25. Toyoshima M., Chida K., Suda T., Sato M., Methotrexate might increase mortality from interstitial lung disease in rheumatoid arthritis. The American Journal of Respiratory and Critical Care Medicine 2012 185 9 1024 2-s2.0-84860649125
26. Inokuma S., Leflunomide-induced interstitial pneumonitis might be a representative of disease-modifying antirheumatic drug-induced lung injury. Expert Opinion on Drug Safety 2011 10 4 603 611 2-s2.0-79958860140 10.1517/14740338.2011.560835
27. Perez-Alvarez R., Perez-de-Lis M., Diaz-Lagares C., Pego-Reigosa J. M., Retamozo S., Bove A., Brito-Zeron P., Bosch X., Ramos-Casals M., Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases. Seminars in Arthritis and Rheumatism 2011 41 2 256 264 2-s2.0-80051801842 10.1016/j.semarthrit.2010.11.002
28. Panopoulos S. T., Sfikakis P. P., Biological treatments and connective tissue disease associated interstitial lung disease. Current Opinion in Pulmonary Medicine 2011 17 5 362 367 2-s2.0-80051781646 10.1097/MCP. 0b013e3283483ea5
29. Agustí C., American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonia. The American Journal of Respiratory and Critical Care Medicine 2002 165 2 277 304 2-s2.0-0036682890
30. Tsuchiya Y., Takayanagi N., Sugiura H., Miyahara Y., Tokunaga D., Kawabata Y., Sugita Y., Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome. European Respiratory Journal 2011 37 6 1411 1417 2-s2.0-79957977676 10.1183/09031936.00019210
31. Lee H. K., Kim D. S., Yoo B. Y., Seo J. B., Rho J., Colby T. V., Kitaichi M., Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 2005 127 6 2019 2027 2-s2.0-21844444817 10.1378/chest.127.6.2019
32. Manjunatha Y. C., Seith A., Kandpal H., Das C. J., Rheumatoid arthritis: spectrum of computed tomographic findings in pulmonary diseases. Current Problems in Diagnostic Radiology 2010 39 6 235 246 2-s2.0-77957086183 10.1067/j.cpradiol.2009.06.002
33. Gutsche M., Rosen G. D., Swigris J. J., Connective tissue disease-associated interstitial lung disease: a review. Current Respiratory Care Reports 2012 1 4 224 232 10.1007/s13665-012-0028-7
34. Mink S. N., Maycher B., Comparative manifestations and diagnostic accuracy of high-resolution computed tomography in usual interstitial pneumonia and nonspecific interstitial pneumonia. Current Opinion in Pulmonary Medicine 2012 18 5 530 534 10.1097/MCP.0b013e3283568026
35. Richman N. C., Yazdany J., Graf J., Chernitskiy V., Imboden J. B., Extraarticular manifestations of rheumatoid arthritis in a multiethnic cohort of predominantly Hispanic and Asian patients. Medicine 2013 92 2 92 97 10.1097/MD.0b013e318289ce01
36. Myasoedova E., Crowson C. S., Turesson C., Gabriel S. E., Matteson E. L., Incidence of extraarticular rheumatoid arthritis in olmsted county, Minnesota, in 1995-2007 versus 1985-1994: a population-based study. Journal of Rheumatology 2011 38 6 983 989 2-s2.0-79957859112 10.3899/jrheum.101133
37. Bartels C. M., Bell C. L., Shinki K., Rosenthal A., Bridges A. J., Changing trends in serious extra-articular manifestations of rheumatoid arthritis among united state veterans over 20 years. Rheumatology 2010 49 9 1670 1675 2-s2.0-77955752827 10.1093/rheumatology/keq135 keq135
38. Habib H. M., Eisa A. A., Arafat W. R., Marie M. A., Pulmonary involvement in early rheumatoid arthritis patients. Clinical Rheumatology 2011 30 2 217 221 2-s2.0-79954438749 10.1007/s10067-010-1492-5
39. Olson A. L., Swigris J. J., Sprunger D. B., Fischer A., Fernandez-Perez E. R., Solomon J., Murphy J., Cohen M., Raghu G., Brown K. K., Rheumatoid arthritis-interstitial lung disease-associated mortality. The American Journal of Respiratory and Critical Care Medicine 2011 183 3 372 378 2-s2.0-79551555761 10.1164/rccm.201004-0622OC
40. Hamblin M. J., Horton M. R., Rheumatoid arthritis-associated interstitial lung disease: diagnostic dilemma. Pulmonary Medicine 2011 2011 12 872120 10.1155/2011/872120
41. Young A., Koduri G., Batley M., Kulinskaya E., Gough A., Norton S., Dixey J., Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology 2007 46 2 350 357 2-s2.0-33846693507 10.1093/rheumatology/kel253 (Pubitemid 46189799)
42. Khan E. A., Stamp L. K., O'Donnell J. L., Chapman P. T., Cardiovascular morbidity in rheumatoid arthritis patients in North Canterbury, New Zealand 1999-2008. International Journal of Rheumatic Diseases 2013 16 1 19 23
43. Stolt P., Källberg H., Lundberg I., Sjögren B., Klareskog L., Alfredsson L., Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Annals of the Rheumatic Diseases 2005 64 4 582 586 2-s2.0-16344369383 10.1136/ard.2004.022053 (Pubitemid 40469088)
44. Caplan A., Certain unusual radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis. Thorax 1953 8 1 29 37 2-s2.0-77049146311
45. Schreiber J., Koschel D., Kekow J., Waldburg N., Goette A., Merget R., Rheumatoid pneumoconiosis (Caplan's syndrome). European Journal of Internal Medicine 2010 21 3 168 172 2-s2.0-77952424547 10.1016/j.ejim.2010.02.004
46. Cohen R. A. C., Patel A., Green F. H. Y., Lung disease caused by exposure to coal mine and silica dust. Seminars in Respiratory and Critical Care Medicine 2008 29 6 651 661 2-s2.0-61849115705 10.1055/s-0028-1101275
47. Yahya A., Bengtsson C., Lai T. C., Larsson P. T., Mustafa A. N., Abdullah N. A., Muhamad N., Hussein H., Klareskog L., Alfredsson L., Murad S., Smoking is associated with an increased risk of developing ACPA-positive but not ACPA-negative rheumatoid arthritis in Asian populations: evidence from the Malaysian MyEIRA case-control study. Modern Rheumatology 2012 22 4 524 531 2-s2.0-80053978522 10.1007/s10165-011-0544-2
48. Mikuls T. R., Sayles H., Yu F., LeVan T., Gould K. A., Thiele G. M., Conn D. L., Jonas B. L., Callahan L. F., Smith E., Brasington R., Moreland L. W., Reynolds R. J., Bridges S. L. Jr., Associations of cigarette smoking with rheumatoid arthritis in African Americans. Arthritis and Rheumatism 2010 62 12 3560 3568 2-s2.0-78650052162 10.1002/art.27716
49. Hutchinson D., Shepstone L., Moots R., Lear J. T., Lynch M. P., Heavy cigarette smoking is strongly associated with rheumatoid arthritis (RA), particularly in patients without a family history of RA. Annals of the Rheumatic Diseases 2001 60 3 223 227 2-s2.0-0035094575 10.1136/ard.60.3.223 (Pubitemid 32260603)
50. Thorley A. J., Tetley T. D., Pulmonary epithelium, cigarette smoke, and chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Diseases 2007 2 4 409 428 2-s2.0-38049158522
51. Balbi B., Cottin V., Singh S., de Wever W., Herth F. J. F., Robalo Cordeiro C., Smoking-related lung diseases: a clinical perspective. European Respiratory Journal 2010 35 2 231 233 2-s2.0-76149105846 10.1183/09031936. 00189309
52. Vassallo R., Ryu J. H., Smoking-related interstitial lung diseases. Clinics in Chest Medicine 2012 33 1 165 178 2-s2.0-84857388048 10.1016/j.ccm.2011.11.004
53. Westedt M. L., Hazes J. M. W., Breedveld F. C., Sterk P. J., Dijkman J. H., Cigarette smoking and pulmonary diffusion defects in rheumatoid arthritis. Rheumatology International 1998 18 1 1 4 2-s2.0-0031864811 10.1007/s002960050045 (Pubitemid 28301540)
54. Saag K. G., Kolluri S., Koehnke R. K., Georgou T. A., Rachow J. W., Hunninghake G. W., Schwartz D. A., Rheumatoid arthritis lung disease: determinants of radiographic and physiologic abnormalities. Arthritis and Rheumatism 1996 39 10 1711 1719 2-s2.0-0029778130 (Pubitemid 26331025)
55. Gochuico B. R., Avila N. A., Chow C. K., Novero L. J., Wu H., Ren P., MacDonald S. D., Travis W. D., Stylianou M. P., Rosas I. O., Progressive preclinical interstitial lung disease in rheumatoid arthritis. Archives of Internal Medicine 2008 168 2 159 166 2-s2.0-38749092931 10.1001/archinternmed. 2007.59 (Pubitemid 351185882)
56. Sakaida H., IgG rheumatoid factor in rheumatoid arthritis with interstitial lung disease. Ryumachi 1995 35 4 671 677 2-s2.0-0029157765
57. Alexiou I., Germenis A., Koutroumpas A., Kontogianni A., Theodoridou K., Sakkas L. I., Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis. Clinical Rheumatology 2008 27 4 511 513 2-s2.0-40949102336 10.1007/s10067-007- 0800-1
58. Aubart F., Crestani B., Nicaise-Roland P., Tubach F., Bollet C., Dawidowicz K., Quintin E., Hayem G., Palazzo E., Meyer O., Chollet-Martin S., Dieudé P., High levels of anti-cyclic citrullinated peptide autoantibodies are associated with co-occurrence of pulmonary diseases with rheumatoid arthritis. Journal of Rheumatology 2011 38 6 979 982 2-s2.0-79957876602 10.3899/jrheum.101261
59. Inui N., Enomoto N., Suda T., Kageyama Y., Watanabe H., Chida K., Anti-cyclic citrullinated peptide antibodies in lung diseases associated with rheumatoid arthritis. Clinical Biochemistry 2008 41 13 1074 1077 2-s2.0-49349108743 10.1016/j.clinbiochem.2008.06.014
60. Fischer A., Solomon J. J., du Bois R. M., Deane K. D., Olson A. L., Fernandez-Perez E. R., Huie T. J., Stevens A. D., Gill M. B., Rabinovitch A. M., Lynch D. A., Burns D. A., Pineiro I. S., Groshong S. D., Achcar R. D. D., Brown K. K., Martin R. J., Swigris J. J., Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease. Respiratory Medicine 2012 106 7 1040 1047 10.1016/j.rmed.2012.03.006
61. Gizinski A. M., Mascolo M., Loucks J. L., Kervitsky A., Meehan R. T., Brown K. K., Holers V. M., Deane K. D., Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA. Clinical Rheumatology 2009 28 5 611 613 2-s2.0-64449083863 10.1007/s10067-009-1128-9
62. Bongartz T., Cantaert T., Atkins S. R., Harle P., Myers J. L., Turesson C., Ryu J. H., Baeten D., Matteson E. L., Citrullination in extra-articular manifestations of rheumatoid arthritis. Rheumatology 2007 46 1 70 75 2-s2.0-33845568288 10.1093/rheumatology/kel202 (Pubitemid 44932787)
63. Harlow L., Rosas I. O., Gochuico B. R., Mikuls T. R., Dellaripa P. F., Oddis C. V., Ascherman D. P., Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease. Arthritis and Rheumatisms 2013 65 4 869 879 10.1002/art.37881
64. Klareskog L., Malmström V., Lundberg K., Padyukov L., Alfredsson L., Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. Seminars in Immunology 2011 23 2 92 98 2-s2.0-79953162113 10.1016/j.smim.2011.01.014
65. Migita K., Nakamura T., Koga T., Eguchi K., HLA-DRB1 alleles and rheumatoid arthritis-related pulmonary fibrosis. Journal of Rheumatology 2010 37 1 205 207 2-s2.0-73649117029 10.3899/jrheum.090303
66. Furukawa H., Oka S., Shimada K., Sugii S., Ohashi J., Matsui T., Ikenaka T., Nakayama H., Hashimoto A., Takaoka H., Arinuma Y., Okazaki Y., Futami H., Komiya A., Fukui N., Nakamura T., Migita K., Suda A., Nagaoka S., Tsuchiya N., Tohma S., Association of human leukocyte antigen with interstitial lung disease in rheumatoid arthritis: a protective role for shared epitope. PLoS ONE 2012 7 5 2-s2.0-84860649671 10.1371/journal.pone.0033133 e33133
67. Gorman J. D., Lum R. F., Chen J. J., Suarez-Almazor M. E., Thomson G., Criswell L. A., Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients. Arthritis and Rheumatism 2004 50 2 400 412 2-s2.0-1042290329 10.1002/art.20006 (Pubitemid 38198824)
68. Gorman J. D., David-Vaudey E., Pai M., Lum R. F., Criswell L. A., Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis. Arthritis and Rheumatism 2004 50 11 3476 3484 2-s2.0-8444232859 10.1002/art.20588 (Pubitemid 39488672)
69. Santiago-Casas Y., González-Rivera T. C., Castro-Santana L. E., Ríos G., Martínez D., Rodríguez V. E., González- Alcover R., Mayor A. M., Vilá L. M., Impact of age on clinical manifestations and outcome in Puerto Ricans with rheumatoid arthritis. Ethnicity and Disease 2010 20 supplement 1 S1 S191 2-s2.0-77955489701
70. Turesson C., O'Fallon W. M., Crowson C. S., Gabriel S. E., Matteson E. L., Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Annals of the Rheumatic Diseases 2003 62 8 722 727 2-s2.0-0038336741 10.1136/ard.62.8.722 (Pubitemid 36886405)
71. Saravanan V., Kelly C., Drug-related pulmonary problems in patients with rheumatoid arthritis. Rheumatology 2006 45 7 787 789 2-s2.0-33745600395 10.1093/rheumatology/kel075 (Pubitemid 43985362)
72. Furukawa H., Oka S., Shimada K., Rheumatoid Arthritis-Interstitial Lung Disease Study Consortium, Tsuchiya N., Tohma S., HLA-A-31:01 and methotrexate-induced interstitial lung disease in Japanese rheumatoid arthritis patients: a multidrug hypersensitivity marker? Annals of the Rheumatic Diseases 2013 72 1 153 155
73. Shidara K., Hoshi D., Inoue E., Yamada T., Nakajima A., Taniguchi A., Hara M., Momohara S., Kamatani N., Yamanaka H., Incidence of and risk factors for interstitial pneumonia in patients with rheumatoid arthritis in a large Japanese observational cohort, IORRA. Modern Rheumatology 2010 20 3 280 286 2-s2.0-77956640184
74. Jordan S. R., Stevanovic V. R., Herbison P., Dockerty J., Highton J., Methotrexate pneumonitis in rheumatoid arthritis: increased prevalence with increasing latitude: an epidemiological study of trends in New Zealand. Journal of Clinical Rheumatology 2011 17 7 356 357 2-s2.0-80053347486 10.1097/RHU.0b013e3182314e34
75. Carroll G. J., Thomas R., Phatouros C. C., Atchison M. H., Leslie A.-., Cook N. J., D'Souza I., Incidence, prevalence and possible risk factors for pneumonitis in patients with rheumatoid arthritis receiving methotrexate. Journal of Rheumatology 1994 21 1 51 54 2-s2.0-0027976651 (Pubitemid 24044917)
76. Ju J. H., Kim S. I., Lee J. H., Lee S., Yoo W., Choe J., Chung S., Lee J., Lee Y., Lee S., Yoon H., Yoon C., Kim H., Park S., Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis. Arthritis and Rheumatism 2007 56 6 2094 2096 2-s2.0-34447517421 10.1002/art.22666 (Pubitemid 47110410)
77. Chikura B., Lane S., Dawson J. K., Clinical expression of leflunomide-induced pneumonitis. Rheumatology 2009 48 9 1065 1068 2-s2.0-70349783402 10.1093/rheumatology/kep050
78. Sawada T., Inokuma S., Sato T., Otsuka T., Saeki Y., Takeuchi T., Matsuda T., Takemura T., Sagawa A., Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis. Rheumatology 2009 48 9 1069 1072 2-s2.0-70349785354 10.1093/rheumatology/kep052
79. Martin N., Innes J. A., Lambert C. M., Turnbull C. M., Wallace W. A. H., Hypersensitivity pneumonitis associated with leflunomide therapy. Journal of Rheumatology 2007 34 9 1934 1937 2-s2.0-35948953881 (Pubitemid 350067658)
80. Namba T., Tanaka K.-., Ito Y., Hoshino T., Matoyama M., Yamakawa N., Isohama Y., Azuma A., Mizushima T., Induction of EMT-like phenotypes by an active metabolite of leflunomide and its contribution to pulmonary fibrosis. Cell Death and Differentiation 2010 17 12 1882 1895 2-s2.0-78349303804 10.1038/cdd.2010.64
81. Hinz B., Phan S. H., Thannickal V. J., Galli A., Bochaton-Piallat M., Gabbiani G., The myofibroblast: one function, multiple origins. The American Journal of Pathology 2007 170 6 1807 1816 2-s2.0-34447309766 10.2353/ajpath.2007.070112 (Pubitemid 47339255)
82. Peno-Green L., Lluberas G., Kingsley T., Brantley S., Lung injury linked to etanercept therapy. Chest 2002 122 5 1858 1860 2-s2.0-0036434878 10.1378/chest.122.5.1858 (Pubitemid 35366106)
83. Perez-Alvarez R., Perez-de-Lis M., Diaz-Lagares C., Pego-Reigosa J. M., Retamozo S., Bove A., Brito-Zeron P., Bosch X., Ramos-Casals M., Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases. Seminars in Arthritis and Rheumatism 2011 41 2 256 264 2-s2.0-80051801842 10.1016/j.semarthrit.2010.11.002
84. Pearce F., Johnson S. R., Courtney P., Interstitial lung disease following certolizumab pegol. Rheumatology 2012 51 3 578 580 2-s2.0-84857526103 10.1093/rheumatology/ker309 ker309
85. Caporali R., Pallavicini F. B., Filippini M., Gorla R., Marchesoni A., Favalli E. G., Sarzi-Puttini P., Atzeni F., Montecucco C., Treatment of rheumatoid arthritis with anti-TNF- α agents: a reappraisal. Autoimmunity Reviews 2009 8 3 274 280 2-s2.0-58749116632 10.1016/j.autrev.2008.11.003
86. Montecucco C., Caporali R., Matucci-Cerinic M., Updating the Italian society for rheumatology recommendations for biologic therapy in adult patients with inflammatory rheumatic diseases. Clinical and experimental rheumatology 2011 29 3, supplement 66 S3 S6 2-s2.0-80055099357
87. Schuller A., Coudurier M., Lega J. C., Khouatra C., Cottin V., Cordier J. F., Interstitial lung disease and anti-TNF- α therapy in rheumatoid arthritis: two different patterns? Revue des Maladies Respiratoires 2010 27 3 232 237 2-s2.0-77954691119 10.1016/j.rmr.2010.01.011
88. Mori S., Imamura F., Kiyofuji C., Sugimoto M., Development of interstitial pneumonia in a rheumatoid arthritis patient treated with infliximab, an anti-tumor necrosis factor α -neutralizing antibody. Modern Rheumatology 2006 16 4 251 255 2-s2.0-33747312637 10.1007/s10165-006-0491-5
89. Ye Q., Dai H., Sarria R., Guzman J., Costabel U., Increased expression of tumor necrosis factor receptors in cryptogenic organizing pneumonia. Respiratory Medicine 2011 105 2 292 297 2-s2.0-78651400169 10.1016/j.rmed.2010. 10.022
90. Thomson E. M., Williams A., Yauk C. L., Vincent R., Overexpression of tumor necrosis factor- α in the lungs alters immune response, matrix remodeling, and repair and maintenance pathways. The American Journal of Pathology 2012 180 4 1413 1430 2-s2.0-84859041558 10.1016/j.ajpath.2011.12.020
91. Mikami Y., Yamauchi Y., Horie M., Kase M., Jo T., Takizawa H., Kohyama T., Nagase T., Tumor necrosis factor superfamily member LIGHT induces epithelial-mesenchymal transition in A549 human alveolar epithelial cells. Biochemical Biophysical Research Communication 2012 428 4 451 457 10.1016/j.bbrc.2012.10.097
92. Sen S., Peltz C., Jordan K., Boes T. J., Infliximab-induced nonspecific interstitial pneumonia. The American Journal of the Medical Sciences 2012 344 1 78 78 10.1097/MAJ.0b013e31824c07e8
93. Kuroki M., Noguchi Y., Shimono M., Tomono K., Tashiro T., Obata Y., Nakayama E., Kohno S., Repression of bleomycin-induced pneumopathy by TNF. Journal of Immunology 2003 170 1 567 574 2-s2.0-0037218733 (Pubitemid 36026184)
94. Wynn T. A., Fibrotic disease and the TH1/TH2 paradigm. Nature Reviews Immunology 2004 4 8 583 594 2-s2.0-3543107212
95. Mirkov M. U., Cui J., Vermeulen S. H., Genomenome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 2013 72 8 1375 1381 10.1136/annrheumdis-2012-202405
96. Ceccarelli F., D'Alfonso S., Perricone C., Carlomagno Y., Alessandri C., Croia C., Barizzone N., Montecucco C., Galeazzi M., Sebastiani G. D., Minisola G., Fiocco U., Valesini G., The role of eight polymorphisms in three candidate genes in determining the susceptibility, phenotype, and response to anti-TNF therapy in patients with rheumatoid arthritis. Clinical and Experimental Rheumatology 2012 30 6 939 942
97. Dixon W. G., Hyrich K. L., Watson K. D., Lunt M., Symmons D. P. M., Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British society for rheumatology biologics register. Annals of the Rheumatic Diseases 2010 69 6 1086 1091 2-s2.0-77953724167 10.1136/ard.2009.120626
98. Herrinton L. J., Harrold L. R., Liu L., Raebel M. A., Taharka A., Winthrop K. L., Solomon D. H., Curtis J. R., Lewis J. D., Saag K. G., Association between anti-TNF- α therapy and interstitial lung disease. Pharmacoepidemiology and Drug Safety 2013 22 4 394 402 10.1002/pds.3409
99. Vassallo R., Matteson E., Thomas C. F. Jr., Clinical response of rheumatoid arthritis-associated pulmonary fibrosis to tumor necrosis factor- α inhibition. Chest 2002 122 3 1093 1096 2-s2.0-0036382949 10.1378/chest.122.3.1093
100. Bargagli E., Galeazzi M., Rottoli P., Infliximab treatment in a patient with rheumatoid arthritis and pulmonary fibrosis. European Respiratory Journal 2004 24 4 708 2-s2.0-6444224776 10.1183/09031936.04.00076904 (Pubitemid 39406147)
101. Antoniou K. M., Mamoulaki M., Malagari K., Kritikos H. D., Bouros D., Siafakas N. M., Boumpas D. T., Infliximab therapy in pulmonary fibrosis associated with collagen vascular disease. Clinical and Experimental Rheumatology 2007 25 1 23 28 2-s2.0-33947587709 (Pubitemid 46477481)
102. Wang Y., Xu S. Q., Xu J. H., Ding C., Treatment with etanercept in a patient with rheumatoid arthritis-associated interstitial lung disease. Clinical Medicine Insights: Case Reports 2011 4 49 52 2-s2.0-80555146743 10.4137/CCRep.S8150
103. Horai Y., Miyamura T., Shimada K., Takahama S., Minami R., Yamamoto M., Suematsu E., Eternacept for the treatment of patients with rheumatoid arthritis and concurrent interstitial lung disease. Journal of Clinical Pharmacy and Therapeutics 2012 37 1 117 121 2-s2.0-84856335082 10.1111/j.1365-2710.2010. 01234.x
104. Komiya K., Ishii H., Fujita N., Oka H., Iwata A., Sonoda H., Kadota J., Adalimumab-induced interstitial pneumonia with an improvement of pre-existing rheumatoid arthritis-associated lung involvement. Internal Medicine 2011 50 7 749 751 2-s2.0-79953762956 10.2169/internalmedicine.50.4748
105. Wagner S. A., Mehta A. C., Laber D. A., Rituximab-induced interstitial lung disease. The American Journal of Hematology 2007 82 10 916 919 2-s2.0-34848909646 10.1002/ajh.20910 (Pubitemid 47502698)
106. Ram R., Ben-Bassat I., Shpilberg O., Polliack A., Raanani P., The late adverse events of rituximab therapy-rare but there! Leukemia and Lymphoma 2009 50 7 1083 1095 2-s2.0-67749087489 10.1080/10428190902934944
107. Wu Y., Jia Y., Xu J., Shuai X., Wu Y., Fatal interstitial lung disease induced by rituximab-containing chemotherapy, treatment with TNF- α antagonist and cytokine profiling: a case-report and review of the literature. Journal of Clinical Pharmacy and Therapeutics 2013 38 3 249 253 10.1111/jcpt.12052
108. Thorley A. J., Tetley T. D., Pulmonary epithelium, cigarette smoke, and chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Diseases 2007 2 4 409 428 2-s2.0-38049158522
109. Yang Q., Underwood M. J., Hsin M. K. Y., Liu X. C., He G. W., Dysfunction of pulmonary vascular endothelium in chronic obstructive pulmonary disease: basic considerations for future drug development. Current Drug Metabolism 2008 9 7 661 667 2-s2.0-52449133912 10.2174/138920008785821684
110. Baka Z., Buzás E., Nagy G., Rheumatoid arthritis and smoking: putting the pieces together. Arthritis Research and Therapy 2009 11 4 238 2-s2.0-73349089655
111. Mathews J. D., Hooper B. M., Whittingham S., Mackay I. R., Stenhouse N. S., Association of autoantibodies with smoking, cardiovascular morbidity, and death in the Busselton population. The Lancet 1973 2 7832 754 758 2-s2.0-0015901245
112. Tuomi T., Heliovaara M., Palosuo T., Aho K., Smoking, lung function, and rheumatoid factors. Annals of the Rheumatic Diseases 1990 49 10 753 756 2-s2.0-0025036958 (Pubitemid 20346377)
113. Wilson M. S., Wynn T. A., Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunology 2009 2 2 103 121 2-s2.0-60649102339 10.1038/mi.2008.85
114. Farhat S. C. L., Silva C. A., Orione M. A. M., Campos L. M. A., Sallum A. M. E., Braga A. L. F., Air pollution in autoimmune rheumatic diseases: a review. Autoimmunity Reviews 2011 11 1 14 21 2-s2.0-80855131428 10.1016/j.autrev.2011.06.008
115. Yousem S. A., Colby T. V., Carrington C. B., Lung biopsy in rheumatoid arthritis. The American Review of Respiratory Disease 1985 131 5 770 777 2-s2.0-0021837965 (Pubitemid 15066866)
116. Manzo A., Vitolo B., Humby F., Caporali R., Jarrossay D., Dell'Accio F., Ciardelli L., Uguccioni M., Montecucco C., Pitzalis C., Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint. Arthritis and Rheumatism 2008 58 11 3377 3387 2-s2.0-55849110806 10.1002/art.23966
117. Atkins S. R., Turesson C., Myers J. L., Tazelaar H. D., Ryu J. H., Matteson E. L., Bongartz T., Morphologic and quantitative assessment of CD20+ B cell infiltrates in rheumatoid arthritis-associated nonspecific interstitial pneumonia and usual interstitial pneumonia. Arthritis and Rheumatism 2006 54 2 635 641 2-s2.0-32444431507 10.1002/art.21758 (Pubitemid 43228642)
118. Turesson C., Matteson E. L., Colby T. V., Vuk-Pavlovic Z., Vassallo R., Weyand C. M., Tazelaar H. D., Limper A. H., Increased CD4+ T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis. Arthritis and Rheumatism 2005 52 1 73 79 2-s2.0-12344291109 10.1002/art.20765 (Pubitemid 40129234)
119. Nagasawa Y., Takada T., Shimizu T., Narita J., Moriyama H., Terada M., Suzuki E., Gejyo F., Inflammatory cells in lung disease associated with rheumatoid arthritis. Internal Medicine 2009 48 14 1209 1217 2-s2.0-70349546880 10.2169/internalmedicine.48.1841
120. Hoser G., Kawiak J., Domagała-Kulawik J., Kopiński P., Droszcz W., Flow cytometric evaluation of lymphocyte subpopulations in BALF of healthy smokers and nonsmokers. Folia Histochemica et Cytobiologica 1999 37 1 25 30 2-s2.0-0032950132 (Pubitemid 29067626)
121. Garcia J. G. N., James H. L., Zinkgraf S., Perlman M. B., Keogh B. A., Lower respiratory tract abnormalities in rheumatoid interstitial lung disease. Potential role of neutrophils in lung injury. The American Review of Respiratory Disease 1987 136 4 811 817 2-s2.0-0023589272 (Pubitemid 18028600)
122. Keith R. C., Powers J. L., Redente E. F., Sergew A., Martin R. J., Gizinski A., Holers V. M., Sakaguchi S., Riches D. W. H., A novel model of rheumatoid arthritis-associated interstitial lung disease in SKG mice. Experimental Lung Research 2012 38 2 55 66 2-s2.0-84856682712 10.3109/01902148.2011.636139
123. Zhang K., Gharaee-Kermani M., McGarry B., Remick D., Phan S. H., TNF- α -mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis. Journal of Immunology 1997 158 2 954 959 2-s2.0-0031568010 (Pubitemid 127492676)
124. Lundblad L. K. A., Thompson-Figueroa J., Leclair T., Sullivan M. J., Poynter M. E., Irvin C. G., Bates J. H. T., Tumor necrosis factor- α overexpression in lung disease: a single cause behind a complex phenotype. The American Journal of Respiratory and Critical Care Medicine 2005 171 12 1363 1370 2-s2.0-20444415267 10.1164/rccm.200410-1349OC (Pubitemid 40800508)
125. Vasakova M., Striz I., Slavcev A., Jandova S., Dutka J., Terl M., Kolesar L., Sulc J., Correlation of IL-1 α and IL-4 gene polymorphisms and clinical parameters in idiopathic pulmonary fibrosis. Scandinavian Journal of Immunology 2007 65 3 265 270 2-s2.0-33847160727 10.1111/j.1365-3083.2007.01896.x (Pubitemid 46277053)
126. Rangel-Moreno J., Hartson L., Navarro C., Gaxiola M., Selman M., Randall T. D., Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. Journal of Clinical Investigation 2006 116 12 3183 3194 2-s2.0-33845303956 10.1172/JCI28756 (Pubitemid 44878632)
127. Agostini C., Gurrieri C., Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis. Proceedings of the American Thoracic Society 2006 3 4 357 363 2-s2.0-33744919279 10.1513/pats.200601-010TK (Pubitemid 43845413)
128. Vignaud J. M., Allam M., Martinet N., Pech M., Plenat F., Martinet Y., Presence of platelet-derived growth factor in normal and fibrotic lung is specifically associated with interstitial macrophages, while both interstitial macrophages and alveolar epithelial cells express the c-sis proto-oncogene. The American Journal of Respiratory Cell and Molecular Biology 1991 5 6 531 538 2-s2.0-0026279912
129. Battegay E. J., Raines E. W., Colbert T., Ross R., TNF- α stimulation of fibroblast proliferation: dependence on platelet-derived growth factor (PDGF) secretion and alteration of PDGF receptor expression. Journal of Immunology 1995 154 11 6040 6047 2-s2.0-0028989485
130. Abdollahi A., Li M., Ping G., Plathow C., Domhan S., Kiessling F., Lee L. B., McMahon G., Gröne H., Lipson K. E., Huber P. E., Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. Journal of Experimental Medicine 2005 201 6 925 935 2-s2.0-20244364391 10.1084/jem.20041393 (Pubitemid 40524462)
131. Ramos C., Montaño M., García-Alvarez J., Ruiz V., Uhal B. D., Selman M., Pardo A., Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. The American Journal of Respiratory Cell and Molecular Biology 2001 24 5 591 598 2-s2.0-0035026949 (Pubitemid 32442767)
132. Dunkern T. R., Feurstein D., Rossi G. A., Sabatini F., Hatzelmann A., Inhibition of TGF- β induced lung fibroblast to myofibroblast conversion by phosphodiesterase inhibiting drugs and activators of soluble guanylyl cyclase. European Journal of Pharmacology 2007 572 1 12 22 2-s2.0-34548498378 10.1016/j.ejphar.2007.06.036 (Pubitemid 47374681)
133. Dawson J. K., Fewins H. E., Desmond J., Lynch M. P., Graham D. R., Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax 2001 56 8 622 627 2-s2.0-0034895195 10.1136/thorax.56.8.622 (Pubitemid 32706144)
134. Wallaert B., Hatron P. Y., Grosbois J. M., Tonnel A. B., Devulder B., Voisin C., Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function. The American Review of Respiratory Disease 1986 133 4 574 580 2-s2.0-0022627757 (Pubitemid 16127240)
135. Salaffi F., Manganelli P., Carotti M., Baldelli S., The differing patterns of subclinical pulmonary involvement in connective tissue diseases as shown by application of factor analysis. Clinical Rheumatology 2000 19 1 35 41 2-s2.0-0034100166 10.1007/s100670050008 (Pubitemid 30123239)
136. Biederer J., Schnabel A., Muhle C., Gross W. L., Heller M., Reuter M., Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis. European Radiology 2004 14 2 272 280 2-s2.0-0842280636 10.1007/s00330-003-2026-1 (Pubitemid 38181084)
137. Kinoshita F., Hamano H., Harada H., Kinoshita T., Igishi T., Hagino H., Ogawa T., Role of KL-6 in evaluating the disease severity of rheumatoid lung disease: comparison with HRCT. Respiratory Medicine 2004 98 11 1131 1137 2-s2.0-4844229366 10.1016/j.rmed.2004.04.003 (Pubitemid 39317944)
138. Oyama T., Kohno N., Yokoyama A., Hirasawa Y., Hiwada K., Oyama H., Okuda Y., Takasugi K., Detection of interstitial pneumonitis in patients with rheumatoid arthritis by measuring circulating levels of KL-6, a human MUC1 mucin. Lung 1997 175 6 379 385 2-s2.0-0030963799 10.1007/PL00007584 (Pubitemid 27431215)
139. Horie S., Nakada K., Minota S., Kano S., High proliferative potential colony-forming cells (HPP-CFCs) in the peripheral blood of rheumatoid arthritis patients with interstitial lung disease. Scandinavian Journal of Rheumatology 2003 32 5 273 276 2-s2.0-0344010234 10.1080/03009740310003893 (Pubitemid 37463958)
140. Fujita J., Dobashi N., Ohtsuki Y., Yamadori I., Yoshinouchi T., Kamei T., Tokuda M., Hojo S., Okada H., Takahara J., Elevation of anti-cytokeratin 19 antibody in sera of the patients with idiopathic pulmonary fibrosis and pulmonary fibrosis associated with collagen vascular disorders. Lung 1999 177 5 311 319 2-s2.0-0032863068 10.1007/PL00007649 (Pubitemid 29420469)
141. Maniwa K., Ogushi F., Tani K., Ohmoto Y., Muraguchi M., Sone S., Increased incidence of autoantibodies to interleukin-1 α in rheumatoid arthritis with interstitial lung disease. Respirology 2000 5 4 315 320 2-s2.0-0034527042 10.1046/j.1440-1843.2000.00269.x (Pubitemid 32049492)
142. Mammen A. L., Dermatomyositis and polymyositis: clinical presentation, autoantibodies, and pathogenesis. Annals of the New York Academy of Sciences 2010 1184 134 153 2-s2.0-77949877102 10.1111/j.1749-6632.2009.05119.x
143. Cavagna L., Fusetti C., Montecucco C., Caporali R., Anticyclic citrullinated peptide antibodies as markers of erosive arthritis in antisynthetase syndrome. Journal of Rheumatology 2010 37 9 1967 2-s2.0-77956492558 10.3899/jrheum.091402
144. Koreeda Y., Higashimoto I., Yamamoto M., Takahashi M., Kaji K., Fujimoto M., Kuwana M., Fukuda Y., Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies. Internal Medicine 2010 49 5 361 369 2-s2.0-77749321069 10.2169/internalmedicine. 49.2889
145. Stanciu R., Guiguet M., Musset L., Touitou D., Beigelman C., Rigolet A., Costedoat-Chalumeau N., Allenbach Y., Hervier B., Dubourg O., Maisonobe T., Charuel J. L., Behin A., Herson S., Amoura Z., Grenier P., Benveniste O., Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use. Journal of Rheumatology 2012 39 9 1835 1839 10.3899/jrheum.111604
146. Marzouk K., Corate L., Saleh S., Sharma O. P., Epstein-Barr-virus-induced interstitial lung disease. Current Opinion in Pulmonary Medicine 2005 11 5 456 460 2-s2.0-24744468034 (Pubitemid 41291092)
147. Müller C. A., Hebart H., Roos A., Roos H., Steidle M., Einsele H., Correlation of interstitial pneumonia with human cytomegalovirus-induced lung infection and graft-versus-host disease after bone marrow transplantation. Medical Microbiology and Immunology 1995 184 3 115 121 2-s2.0-0028799053
148. Cavagna L., Caporali R., Therapeutic options in anti-Jo1 antisynthetase syndrome with interstitial lung disease. Arthritis Care and Research 2013 65 9 1548 10.1002/acr.22024
149. Antoniou K. M., Margaritopoulos G., Economidou F., Siafakas N. M., Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement. European Respiratory Journal 2009 33 4 882 896 2-s2.0-63849343420 10.1183/09031936.00152607
150. Lamblin C., Bergoin C., Saelens T., Wallaert B., Interstitial lung diseases in collagen vascular diseases. European Respiratory Journal Supplement 2001 18 32 69 80 2-s2.0-0035464548
151. Kelly C., Saravanan V., Treatment strategies for a rheumatoid arthritis patient with interstitial lung disease. Expert Opinion on Pharmacotherapy 2008 9 18 3221 3230 2-s2.0-59449099980 10.1517/14656560802591430
152. Saketkoo L. A., Espinoza L. R., Rheumatoid arthritis interstitial lung disease: mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug. Archives of Internal Medicine 2008 168 15 1718 1719 2-s2.0-49449101589 10.1001/archinte.168.15.1718
153. Puttick M. P. E., Klinkhoff A. V., Chalmers A., Ostrow D. N., Treatment of progressive rheumatoid interstitial lung disease with cyclosporine. Journal of Rheumatology 1995 22 11 2163 2165 2-s2.0-0028851805
154. Ogawa D., Hashimoto H., Wada J., Ueno A., Yamasaki Y., Yamamura M., Makino H., Successful use of cyclosporin A for the treatment of acute interstitial pneumonitis associated with rheumatoid arthritis. Rheumatology 2000 39 12 1422 1424 2-s2.0-0034508677 (Pubitemid 32045870)
155. Chang H. K., Park W., Ryu D. S., Successful treatment of progressive rheumatoid interstitial lung disease with cyclosporine: a case report. Journal of Korean medical science 2002 17 2 270 273 2-s2.0-0036546355
156. Metafratzi Z. M., Georgiadis A. N., Ioannidou C. V., Alamanos Y., Vassiliou M. P., Zikou A. K., Raptis G., Drosos A. A., Efremidis S. C., Pulmonary involvement in patients with early rheumatoid arthritis. Scandinavian Journal of Rheumatology 2007 36 5 338 344 2-s2.0-35648943308 10.1080/03009740701393957 (Pubitemid 350034803)
157. Rojas-Serrano J., González-Velásquez E., Mejía M., Sánchez-Rodríguez A., Carrillo G., Interstitial lung disease related to rheumatoid arthritis: evolution after treatment. Reumatología Clínica 2012 8 2 68 71 10.1016/j.reuma.2011.12.008
158. Mohr M., Jacobi A. M., Interstitial lung disease in rheumatoid arthritis: response to IL-6R blockade. Scandinavian Journal of Rheumatology 2011 40 5 400 401 2-s2.0-80053406236 10.3109/03009742.2011.599072
159. Hadjinicolaou A. V., Nisar M. K., Bhagat S., Parfrey H., Chilvers E. R., Östör A. J. K., Non-infectious pulmonary complications of newer biological agents for rheumatic diseases-a systematic literature review. Rheumatology 2011 50 12 2297 2305 2-s2.0-82355170761 10.1093/rheumatology/ker289 ker289
160. Kawashiri S. Y., Kawakami A., Sakamoto N., Ishimatsu Y., Eguchi K., A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab. Rheumatology International 2012 32 12 4023 4026 2-s2.0-77952109330 10.1007/s00296-010-1525-z